DEC - JAN19TECH OUTLOOKsolutions to help meet (and exceed!) project requirements. Our multi-disciplinary team will help support your drug development from early-stage planning, design, and implementation right at our facility. Underpinning it all is deep regulatory knowledge of the biggest risks likely to affect your molecule or formulation reaching the market," says Krista Coventry, Senior Director of Clinical Affairs and Regulatory Strategy.For instance, SNI recently completed a clinical study to investigate/validate an innovative diabetes and prediabetes diagnostic screening tool for SciMar's Wellness Transformation Network. Today, SNI is continuing to manage SciMar's extensive diabetes clinical research program, including the development of its novel therapeutic treatment. "Innovation is a key driver in advancing health and wellness research to improve lives across the globe," informs Coventry. "As a CRO, helping companies understand what needs to be done, and planning a roadmap to get there with support from a specialized team, enables clients to bring innovative therapeutics to market." We are problem-solvers. Everything we do, from the beginning, has been about identifying our customers' problems and then working to develop a solution to overcome them
< Page 9 | Page 11 >